Immunological characteristics of experimental murine infection with Leishmania (Leishmania) amazonensis

Veterinary Parasitology

Volumn 158, Issue 4, 2008, Pages 239-255

  Pereira, Bernardo Acácio Santini ^a   Alves, Carlos Roberto ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Immunology; Leishmania (L.) amazonensis; Murine infection

Indexed keywords

ADENOSINE; ANTIBODY; CHEMOKINE; GAMMA INTERFERON; GLUTATHIONE; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; LEUKOTRIENE; PROSTAGLANDIN; SOMATOMEDIN C; THROMBOCYTE ACTIVATING FACTOR; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; COMPLEMENT SYSTEM; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; EXPERIMENTAL INFECTION; GRANULOCYTE; INNATE IMMUNITY; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; NATURAL KILLER T CELL; NONHUMAN; OUTCOME ASSESSMENT; PROMASTIGOTE; REVIEW; TH1 CELL; TH2 CELL;

ANIMALS; ANTIPROTOZOAL AGENTS; LEISHMANIA; LEISHMANIASIS; MICE;

LEISHMANIA AMAZONENSIS; MURINAE; MUS;

EID: 56349116159     PISSN: 03044017     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetpar.2008.09.015     Document Type: Review

References (87)

1. Abreu-Silva A.L., Calabrese K.S., Tedesco R.C., Mortara R.A., and Gonçalves da Costa S.C. Central nervous system involvement in experimental infection with Leishmania (Leishmania) amazonensis. Am. J. Trop. Med. Hyg. 68 (2003) 661-665
2. Afonso L.C., and Scott P. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect. Immun. 61 (1993) 2952-2959
3. Alexander J., and Bryson K. T helper(h)1/Th2 and Leishmania: paradox rather than paradigm. Immunol. Lett. 99 (2005) 17-23
4. Almeida R.P., Barral-Netto M., De Jesus A.M., De Freitas L.A., Carvalho E.M., and Barral A. Biological behavior of Leishmania amazonensis isolated from humans with cutaneous, mucosal, or visceral leishmaniasis in BALB/C mice. Am. J. Trop. Med. Hyg. 54 (1996) 178-184
5. Alves C.R., Benevolo-De-Andrade T.C., Alves J.L., and Pirmez C. Th1 and Th2 immunological profile induced by cysteine proteinase in murine leishmaniasis. Parasite Immunol. 26 (2004) 127-135
6. Alves C.R., Corte-Real S., Bourguignon S.C., Chaves C.S., and Saraiva E.M. Leishmania amazonensis: early proteinase activities during promastigote-amastigote differentiation in vitro. Exp. Parasitol. 109 (2005) 38-48
7. Alves C.R., Pontes de Carvalho L.C., Souza A.L., and De Simone S.G. A strategy for the identification of T-cell epitopes on Leishmania cysteine proteinases. Cytobios 104 (2001) 33-41
8. Aranha F.C., Ribeiro Jr. U., Basse P., Corbett C.E., and Laurenti M.D. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection. Scand. J. Immunol. 62 (2005) 334-341
9. Arnoldi J., and Moll H. Langerhans cell migration in murine cutaneous leishmaniasis: regulation by tumor necrosis factor alpha, interleukin-1 beta, and macrophage inflammatory protein-1 alpha. Dev. Immunol. 6 (1998) 3-11
10. Awasthi A., Mathur R.K., and Saha B. Immune response to Leishmania infection. Indian J. Med. Res. 119 (2004) 238-258
11. Azeredo-Coutinho R.G.B., Conceição-Silva F., Schubach A., Cupolillo E., Quintella R.P., Madeira M.F., Pacheco R.S., Valete-Rosalino C.M., and Mendonça S.C.F. First report of diffuse cutaneous leishmaniasis and Leishmania amazonensis infection in Rio de Janeiro State, Brazil. Trans. R. Soc. Trop. Med. Hyg. 101 (2007) 735-737
12. Balestieri F.M.P., Queiroz A.R.P., Scavone C., Costa V.M.A., Barral-Netto M., and Abrahamsohn I.A. Leishmania (L.) amazonensis-induced inhibition of nitric oxide synthesis in host macrophages. Microbes Infect. 4 (2002) 23-29
13. Barral A., Pedral-Sampaio D., Grimaldi Junior G., Momen H., McMahon-Pratt D., Ribeiro de Jesus A., Almeida R., Badaro R., Barral-Netto M., Carvalho E.M., and Johnson Jr. W.D. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am. J. Trop. Med. Hyg. 44 (1991) 536-546
14. Barral A., Petersen E.A., Sacks D.L., and Neva F.A. Late metastatic leishmaniasis in the mouse. A model for mucocutaneous disease. Am. J. Trop. Med. Hyg. 32 (1983) 277-285
15. Bates P.A., and Rogers M.E. New insights into the developmental biology and transmission mechanisms of Leishmania. Curr. Mol. Med. 4 (2004) 601-609
16. Bertho A.L., Santiago M.A., and Coutinho S.G. An experimental model of the production of metastasis in murine cutaneous leishmaniasis. J. Parasitol. 80 (1994) 93-99
17. Brandonisio O., Spinelli R., and Pepe M. Dendritic cells in Leishmania infection. Microbes Infec. 6 (2004) 1402-1409
18. Calabrese K.S., and Da Costa S.C. Enhancement of Leishmania amazonensis infection in BCG non-responder mice by BCG-antigen specific vaccine. Mem. Inst. Oswaldo Cruz 87 (1992) 49-56
19. Calvopina M., Barroso P.A., Marco J.D., Korenaga M., Cooper P.J., Nonaka S., and Hashiguchi Y. Efficacy of vaccination with a combination of Leishmania amastigote antigens and the lipid A-analogue ONO-4007 for immunoprophylaxis and immunotherapy against Leishmania amazonensis infection in a murine model of New World cutaneous leishmaniasis. Vaccine 24 (2006) 5645-5652
20. Castro R., Scott K., Jordan T., Evans B., Craig J., Peters E.L., and Swiker K. The ultrastructure of the parasitophorous vacuole formed by Leishmania major. J. Parasitol. 92 (2006) 1162-1170
21. Colmenares M., Kima P.E., Samoff E., Soong L., and McMahon-Pratt D. Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection. Infect. Immun. 71 (2003) 3172-3182
22. Costa A.A., Abreu A.L., Gomes C.M., Saldanha A.C., Barral A., Costa J.M., and Corbett C.E. Experimental model of chronic osteomyelitis caused by Leishmania (L) amazonensis. Acta Trop. 98 (2006) 125-129
23. Courret N., Lang T., Milon G., and Antoine J.C. Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice. Int. J. Parasitol. 33 (2003) 1373-1383
24. Cupolilo S.M., Souza C.S., Abreu-Silva A.L., Calabrese K.S., and Goncalves da Costa S.C. Biological behavior of Leishmania (Leishmania) amazonensis isolated from a human diffuse cutaneous leishmaniasis in inbred strains of mice. Histol. Histopathol. 18 (2003) 1059-1065
25. De Freitas Balanço J.M., Moreira M.E., Bonomo A., Bozza P.T., Amarante-Mendes G., Pirmez C., and Barcinski M.A. Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity. Curr. Biol. 11 (2001) 1870-1873
26. De Souza Leão S., Lang T., Prina E., Hellio R., and Antoine J.C. Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells. J. Cell Sci. 108 (1995) 3219-3231
27. Degrossoli A., Bosetto M.C., Lima C.B., and Giorgio S. Expression of hypoxia-inducible factor 1alpha in mononuclear phagocytes infected with Leishmania amazonensis. Immunol. Lett. 114 (2007) 119-125
28. Denkers E.Y., and Butcher B.A. Sabotage and exploitation in macrophages parasitized by intracellular protozoans. Trends Parasitol. 21 (2005) 35-41
29. Felizardo T.C., Toma L.S., Borges N.B., Lima G.M.C.A., and Abrahamsohn I.A. Leishmania (Leishmania) amazonensis infection and dissemination in mice inoculated with stationary-phase or with purified metacyclic promastigotes. Parasitology 134 (2007) 1699-1707
30. Gomes C.M., Goto H., Ribeiro Da Matta V.L., Laurenti M.D., Gidlund M., and Corbett C.E. Insulin-like growth factor (IGF)-I affects parasite growth and host cell migration in experimental cutaneous leishmaniasis. Int. J. Exp. Pathol. 81 (2000) 249-255
31. Gomes I.N., Calabrich A.F., Tavares Rda S., Wietzerbin J., de Freitas L.A., and Veras O.S. Differential properties of CBA/J mononuclear phagocytes recovered from an inflammatory site and probed with two different species of Leishmania. Microbes Infect. 5 (2003) 251-260
32. Gramiccia M., and Gradoni L. The current status of zoonotic leishmaniases and approaches to disease control. Int. J. Parasitol. 35 (2005) 1169-1180
33. Guimarães E.T., Santos L.A., Ribeiro dos Santos R., Teixeira M.M., dos Santos W.L., and Soares M.B. Role of interleukin-4 and prostaglandin E2 in Leishmania amazonensis infection of BALB/c mice. Microbes Infect. 8 (2006) 1219-1226
34. Hernández Sanabria M.X., Afonso L.C., Golgher D., Tafuri W.L., and Vieira L.Q. CD8+ T cells are not required for vaccine-induced immunity against Leishmania amazonensis in IL-12/23P40(-/-) C57BL/6 mice. Microbes Infect. 9 (2007) 1124-1134
35. + en la leishmaniasis cutânea. Salud Publica Mex. 48 (2006) 430-439
36. Ji J., Masterson J., Sun J., and Soong L. CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection. J. Immunol. 174 (2005) 7147-7153
37. Ji J., Sun J., Qi H., and Soong L. Analysis of T helper cell responses during infection with Leishmania amazonensis. Am. J. Trop. Med. Hyg. 66 (2002) 338-345
38. Ji J., Sun J., and Soong L. Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect. Immun. 71 (2003) 4278-4288
39. Jones D.E., Ackermann M.R., Wille U., Hunter C.A., and Scott P. Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. Infect. Immun. 70 (2002) 2151-2158
40. Jones D.E., Buxbaum L.U., and Scott P. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J. Immunol. 165 (2000) 364-372
41. Kima P.E., Constant S.L., Hannum L., Colmenares M., Lee K.S., Haberman A.M., Shlomchik M.J., and McMahon-Pratt D. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J. Exp. Med. 191 (2000) 1063-1080
42. Laskay T., van Zandbergen G., and Solbach W. Neutrophil granulocytes as host cells and transport vehicles for intracellular pathogens: apoptosis as infection-promoting factor. Immunobiology 213 (2008) 183-191
43. Laurenti M.D., Gidlund M., Ura D.M., Sinhorini I.L., Corbett C.E., and Goto H. The role of natural killer cells in the early period of infection in murine cutaneous leishmaniasis. Braz. J. Med. Biol. Res. 32 (1999) 323-325
44. Laurenti M.D., Orn A., Sinhorini I.L., and Corbett C.E. The role of complement in the early phase of Leishmania (Leishmania) amazonensis infection in BALB/c mice. Braz. J. Med. Biol. Res. 37 (2004) 427-434
45. Lemos de Souza V., Ascenção Souza J., Correia Silva T.M., Sampaio Tavares Veras P., and Rodrigues-de-Freitas L.A. Different Leishmania species determine distinct profiles of immune and histopathological responses in CBA mice. Microbes Infect. 2 (2000) 1807-1815
46. Linares E., Augusto O., Barão S.C., and Giorgio S. Leishmania amazonensis infection does not inhibit systemic nitric oxide levels elicited by lipopolysaccharide in vivo. J. Parasitol. 86 (2000) 78-82
47. Lonardoni M.V., Russo M., and Jancar S. Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection. Infect. Immun. 68 (2000) 6355-6361
48. Maioli T.U., Takane E., Arantes R.M., Fietto J.L., and Afonso L.C. Immune response induced by New World Leishmania species in C57BL/6 mice. Parasitol. Res. 94 (2004) 207-212
49. Matthews D.J., Emson C.L., McKenzie G.J., Jolin H.E., Blackwell J.M., and McKenzie A.N. IL-13 is a susceptibility factor for Leishmania major infection. J. Immunol. 164 (2000) 1458-1462
50. Monteiro M.C., Marques F.C., Blazius R.D., Santos da Silva O., de Queiroz Cunha F., Bento D.B., and Torres Romão P.R. N-Acetyl-l-cysteine reduces the parasitism of BALB/c mice infected with Leishmania amazonensis. Parasitol. Res. 102 (2008) 801-803
51. Mukbel R.M., Patten Jr. C., Gibson K., Ghosh M., Petersen C., and Jones D.E. Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide. Am. J. Trop. Med. Hyg. 76 (2007) 669-675
52. Neal R.A., and Hale C. A comparative study of susceptibility of inbred and outbred mouse strains compared with hamsters to infection with New World cutaneous leishmaniases. Parasitology 87 (1983) 7-13
53. Nylén S., and Sacks D. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol. 28 (2007) 378-384
54. O'Garra A., and Vieira P. T(H)1 cells control themselves by producing interleukin-10. Nat. Rev. Immunol. 7 (2007) 425-428
55. Osorio y Fortéa J., Prina E., de La Llave E., Lecoeur H., Lang T., and Milon G. Unveiling pathways used by Leishmania amazonensis amastigotes to subvert macrophage function. Immunol. Rev. 219 (2007) 66-74
56. Padigel U.M., Alexander J., and Farrell J.P. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis. J. Immunol. 171 (2003) 3705-3710
57. Pinheiro R.O., and Rossi-Bergmann B. Interferon-gamma is required for the late but not early control of Leishmania amazonensis infection in C57Bl/6 mice. Mem. Inst. Oswaldo Cruz 102 (2007) 79-82
58. Pompeu M.L., Freitas L.A., Santos M.L., Khouri M., and Barral-Netto M. Granulocytes in the inflammatory process of BALB/c mice infected by Leishmania amazonensis. A quantitative approach. Acta Trop. 48 (1991) 185-193
59. Prina E., Abdi S.Z., Lebastard M., Perret E., Winter N., and Antoine J.C. Dendritic cells as host cells for the promastigote and amastigote stages of Leishmania amazonensis: the role of opsonins in parasite uptake and dendritic cell maturation. J. Cell Sci. 117 (2004) 315-325
60. Qi H., Ji J., Wanasen N., and Soong L. Enhanced replication of Leishmania amazonensis amastigotes in gamma interferon-stimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis. Infect. Immun. 72 (2004) 988-995
61. Qi H., Popov V., and Soong L. Leishmania amazonensis-dendritic cell interactions in vitro and the priming of parasite-specific CD4(+) T cells in vivo. J. Immunol. 167 (2001) 4534-4542
62. Ramer A.E., Vanloubbeeck Y.F., and Jones D.E. Antigen-responsive CD4+ T cells from C3H mice chronically infected with Leishmania amazonensis are impaired in the transition to an effector phenotype. Infect. Immun. 74 (2006) 1547-1554
63. Reithinger R., Dujardin J.C., Louzir H., Pirmez C., Alexander B., and Brooker S. Cutaneous Leishmaniasis. Lancet Infect. Dis. 7 (2007) 581-596
64. Romão P.R., Fonseca S.G., Hothersall J.S., Noronha-Dutra A.A., Ferreira S.H., and Cunha F.Q. Glutathione protects macrophages and Leishmania major against nitric oxide-mediated cytotoxicity. Parasitology 118 (1999) 559-566
65. Sacks D., and Anderson C. Re-examination of the immunosuppressive mechanisms mediating non-cure of Leishmania infection in mice. Immunol. Rev. 201 (2004) 225-238
66. Sacks D., and Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2 (2002) 845-858
67. Santiago H.C., Braga Pires M.F., Souza D.G., Roffê E., Côrtes D.F., Tafuri W.L., Teixeira M.M., and Vieira L.Q. Platelet activating factor receptor-deficient mice present delayed interferon-gamma upregulation and high susceptibility to Leishmania amazonensis infection. Microbes Infect. 8 (2006) 2569-2577
68. Serezani C.H., Perrela J.H., Russo M., Peters-Golden M., and Jancar S. Leukotrienes are essential for the control of Leishmania amazonensis infection and contribute to strain variation in susceptibility. J. Immunol. 177 (2006) 3201-3208
69. Silva E.M., Bertho A.L., and Mendonça S.C. Effect of in vivo depletion of CD4+ T cells on experimental infection of susceptible BALB/c mice with Leishmania amazonensis. Acta Trop. 56 (1994) 111-120
70. Soong L., Chang C.H., Sun J., Longley Jr. B.J., Ruddle N.H., Flavell R.A., and McMahon-Pratt D. Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. J. Immunol. 158 (1997) 5374-5383
71. Subash S., Rita M., and Tim R.M. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 2 (1995) 271-279
72. Teixeira M.J., Teixeira C.R., Andrade B.B., Barral-Netto M., and Barral A. Chemokines in host-parasite interactions in leishmaniasis. Trends Parasitol. 22 (2006) 32-40
73. Terabe M., Kuramochi T., Hatabu T., Ito M., Ueyama Y., Katakura K., Kawazu S., Onodera T., and Matsumoto Y. Non-ulcerative cutaneous lesion in immunodeficient mice with Leishmania amazonensis infection. Parasitol. Int. 48 (1999) 47-53
74. Terabe M., Kuramochi T., Ito M., Hatabu T., Sanjoba C., Chang K.P., Onodera T., and Matsumoto Y. CD4(+) cells are indispensable for ulcer development in murine cutaneous leishmaniasis. Infect. Immun. 68 (2000) 4574-4577
75. Terabe M., Wakana S., Katakura K., Onodera T., Matsumoto Y., and Ito M. Influence of H2 complex and non-H2 genes on progression of cutaneous lesions in mice infected with Leishmania amazonensis. Parasitol. Int. 53 (2004) 217-221
76. Van Zandbergen G., Klinger M., Mueller A., Dannenberg S., Gebert A., Solbach W., and Laskay T. Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J. Immunol. 173 (2004) 6521-6525
77. Vasquez R.E., and Soong L. CXCL10/gamma interferon-inducible protein 10-mediated protection against Leishmania amazonensis infection in mice. Infect. Immun. 74 (2006) 6769-6777
78. Vasquez R.E., Xin L., and Soong L. Effects of CXCL10 on dendritic cell and CD4+ T-cell functions during Leishmania amazonensis infection. Infect. Immun. 76 (2008) 161-169
79. Vanloubbeeck Y.F., Ramer A.E., Jie F., and Jones D.E. CD4+ Th1 cells induced by dendritic cell-based immunotherapy in mice chronically infected with Leishmania amazonensis do not promote healing. Infect. Immun. 72 (2004) 4455-4463
80. Vendrame C.M., Carvalho M.D., Rios F.J., Manuli E.R., Petitto-Assis F., and Goto H. Effect of insulin-like growth factor-I on Leishmania amazonensis promastigote arginase activation and reciprocal inhibition of NOS2 pathway in macrophage in vitro. Scand. J. Immunol. 66 (2007) 287-296
81. Von Stebut E., and Udey M.C. Requirements for Th1-dependent immunity against infection with Leishmania major. Microbes Infect. 6 (2004) 1102-1109
82. Wanasen N., Xin L., and Soong L. Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection. Int. J. Parasitol. 38 (2008) 417-429
83. Watanabe Y., Hamaguchi-Tsuru E., Morimoto N., Nishio Y., Yagyu K., Konishi Y., Tominaga M., Miyazaki J., Furuya M., and Tominaga A. IL-5-induced eosinophils suppress the growth of Leishmania amazonensis in vivo and kill promastigotes in vitro in response to either IL-4 or IFN-gamma. DNA Cell Biol. 23 (2004) 412-418
84. - dendritic cell subset and priming Leishmania amazonensis-specific CD4+ T cells in vitro and in vivo. Infec. Immun. 75 (2007) 5018-5026
85. Xin L., Li K., and Soong L. Down-regulation of dendritic cell signaling pathways by Leishmania amazonensis amastigotes. Mol. Immunol. 45 (2008) 3371-3382
86. Yang Z., Mosser D.M., and Zhang X. Activation of the MAPK. ERK following Leishmania amazonensis infection of macrophages. J. Immunol. 178 (2007) 1077-1085
87. Zambrano-Villa S., Rosales-Borjas D., Carrero J.C., and Ortiz-Ortiz L. How protozoan parasites evade the immune response. Trends Parasitol. 18 (2002) 272-278